Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion criteria * Pathologically-proven diagnosis of melanoma. * Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible. Exclusion criteria * Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol. * Any patient unable or unwilling to provide consent.
About the study
The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.
What is being tested
- Tissue and blood collection (other)
Sponsor: Vanderbilt-Ingram Cancer Center · Participants: 3,000 · Started: Jun 3, 2010
Contact the study team
- Vanderbilt-Ingram Service for Timely Access · Phone: 800-811-8480
Official record on ClinicalTrials.gov — NCT01205815
Locations in the U.S.
| Tennessee | Vanderbitl-Ingram Cancer Center, Nashville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.